RedHill Biopharma (RDHL) announced the coverage of Talicia by Humana’s Part D Plan, providing access to Talicia for H. pylori therapy to more ...

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joanna Gajuk from Bank of ...

Shares of RedHill Biopharma Ltd. (NASDAQ:RDHL) climbed 5% intra-day Tuesday following the announcement that its H. pylori treatment, Talicia, is now covered by Humana (NYSE:HUM)'s Part D Plan. This ...

MetLife Inc. Floating Rate Non-Cum. Pfd. Series A 0.08% ...

Part D enrollees with costly prescriptions may be in for serious relief. These are some important updates to pay attention to. Millions of people get their health coverage through Medicare.

The PDP also vowed to persist in its efforts to reclaim the controversial property located at 59 Airport Road, Benin City, Edo State. In an exclusive interview with The PUNCH, the PDP National ...

You can pick your doctor as long as he or she is a Medicare-eligible doctor and in your health system. Part D is our prescription drug plan. You have to have one of those or you will pay a penalty ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

Dec. 11, 2024 — Many vitamins are produced in chemical factories, often synthetically, but researchers have succeeded in developing a natural and simple method for producing vitamin B2: by ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. The only way to get Ozempic online is through a prescription from a licensed ...

Ozempic tops new Medicare price negotiation list FDA bans red dye used in medicines over cancer risk J&J agrees $14.6bn takeover of CNS biotech Intra-Cellular ...